{"id":210760,"date":"2017-02-24T02:08:35","date_gmt":"2017-02-24T07:08:35","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/global-psoriasis-partnering-2010-to-2017-yahoo-finance.php"},"modified":"2017-02-24T02:08:35","modified_gmt":"2017-02-24T07:08:35","slug":"global-psoriasis-partnering-2010-to-2017-yahoo-finance","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/psoriasis-2\/global-psoriasis-partnering-2010-to-2017-yahoo-finance.php","title":{"rendered":"Global Psoriasis Partnering 2010 to 2017 &#8211; Yahoo Finance"},"content":{"rendered":"<p><p>    NEW YORK, Feb. 21, 2017 \/PRNewswire\/ -- Provides understanding    and access to the psoriasis partnering deals and agreements    entered into by the worlds leading healthcare companies.  <\/p>\n<p>    Read the full report: <a href=\"http:\/\/www.reportlinker.com\/p03605692-summary\/view-report.html\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p03605692-summary\/view-report.html<\/a>  <\/p>\n<p>    Description    The Global Psoriasis Partnering Terms and Agreements since 2010    report provides understanding and access to partnering deals    and agreements entered into by the world's leading healthcare    companies.  <\/p>\n<p>    - Trends in partnering deals    - Top deals by value    - Deals listed by company A-Z, industry sector, stage of    development, technology type  <\/p>\n<p>    The report provides understanding and access to the partnering    deals and agreements entered into by the world's leading    healthcare companies.  <\/p>\n<p>    The report provides an analysis of partnering deals. The    majority of deals are discovery or development stage whereby    the licensee obtains a right or an option right to license the    licensors technology. These deals tend to be multicomponent,    starting with collaborative R&D, and commercialization of    outcomes.  <\/p>\n<p>    Understanding the flexibility of a prospective partner's    negotiated deals terms provides critical insight into the    negotiation process in terms of what you can expect to achieve    during the negotiation of terms. Whilst many smaller companies    will be seeking details of the payments clauses, the devil is    in the detail in terms of how payments are triggered  contract    documents provide this insight where press releases do not.  <\/p>\n<p>    This data driven report contains multiple links to online    copies of actual deals and contract documents as submitted to    the Securities Exchange Commission by companies and their    partners, where available. Contract documents provide the    answers to numerous questions about a prospective partner's    flexibility on a wide range of important issues, many of which    will have a significant impact on each party's ability to    derive value from the deal.  <\/p>\n<p>    The initial chapters of this report provide an orientation of    partnering trends.  <\/p>\n<p>    Chapter 1 provides an overview of the trends in partnering    since 2010, including a summary of deals by industry sector,    stage of development, deal type, and technology type.  <\/p>\n<p>    Chapter 2 provides a review of the top 10 most active companies    in the therapy area, including a comprehensive listing of the    deals announced by each company.  <\/p>\n<p>    Chapter 3 provides a comprehensive directory of partnering    deals signed and announced since 2010. The chapter is organized    by company A-Z, stage of development at signing, deal type    (collaborative R&D, co-promotion, licensing etc), and    technology type. Each deal title links via Weblink to an online    version of the deal record, and where available the contract    document, providing easy access to each contract document on    demand.  <\/p>\n<p>    Chapter 4 provides a listing of partnering deals where a    contract document is available alongside the deal record.  <\/p>\n<p>    Chapters 5 and 6 provide a summary of M&A deals since 2010    where the acquired company is active in the therapy area of    interest.  <\/p>\n<p>    Chapters 7 and 8 provide a summary of financings since 2010    where the financed company is active in the therapy area of    interest.  <\/p>\n<p>    In conclusion, this report provides everything a prospective    dealmaker needs to know about partnering in the research,    development and commercialization of technologies and products    in the therapy area.  <\/p>\n<p>    Read the full report: <a href=\"http:\/\/www.reportlinker.com\/p03605692-summary\/view-report.html\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p03605692-summary\/view-report.html<\/a>  <\/p>\n<p>    About Reportlinker    ReportLinker is an award-winning market research solution.    Reportlinker finds and organizes the latest industry data so    you get all the market research you need - instantly, in one    place.  <\/p>\n<p>    <a href=\"http:\/\/www.reportlinker.com\" rel=\"nofollow\">http:\/\/www.reportlinker.com<\/a>  <\/p>\n<p>    __________________________    Contact Clare: <a href=\"mailto:clare@reportlinker.com\">clare@reportlinker.com<\/a>    US: (339)-368-6001    Intl: +1 339-368-6001  <\/p>\n<p>    To view the original version on PR Newswire, visit:<a href=\"http:\/\/www.prnewswire.com\/news-releases\/global-psoriasis-partnering-2010-to-2017-300411256.html\" rel=\"nofollow\">http:\/\/www.prnewswire.com\/news-releases\/global-psoriasis-partnering-2010-to-2017-300411256.html<\/a>  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See original here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/global-psoriasis-partnering-2010-2017-004000054.html\" title=\"Global Psoriasis Partnering 2010 to 2017 - Yahoo Finance\">Global Psoriasis Partnering 2010 to 2017 - Yahoo Finance<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEW YORK, Feb. 21, 2017 \/PRNewswire\/ -- Provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/psoriasis-2\/global-psoriasis-partnering-2010-to-2017-yahoo-finance.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[182497],"tags":[],"class_list":["post-210760","post","type-post","status-publish","format-standard","hentry","category-psoriasis-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/210760"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=210760"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/210760\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=210760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=210760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=210760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}